U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07403487) titled 'Phase II Trial of RC1416 Injection in Asthma' on Jan. 27.
Brief Summary: This study is a phase II study of RC1416 in subjects with severe uncontrolled asthma. The purpose of the study is to evaluate efficacy and safety of RC1416 in subjects with severe uncontrolled asthma.
Study Start Date: March 10
Study Type: INTERVENTIONAL
Condition:
Moderate to Severe Asthma
Intervention:
DRUG: RC1416
There are two doses in this part. Each subjects will receive the drug by subcutaneous injection.
DRUG: RC1416 Placebo
Each subjects will receive the placebo by subcutaneous injection
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Nanjin...